Analysis of Pediatric Drug Approval Lag in Japan
Ueyama, Eiji, Kaneko, Masayuki, Narukawa, Mamoru
Published in Therapeutic innovation & regulatory science (01.03.2021)
Published in Therapeutic innovation & regulatory science (01.03.2021)
Get full text
Journal Article
Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin: a pooled analysis of six randomized, placebo-controlled trials
Kashiwagi, Atsunori, Sakatani, Taishi, Nakamura, Ichiro, Akiyama, Noriko, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Kosakai, Yoshinori
Published in Endocrine Journal (01.01.2018)
Published in Endocrine Journal (01.01.2018)
Get full text
Journal Article
Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study
Kashiwagi, Atsunori, Akiyama, Noriko, Shiga, Takanori, Kazuta, Kenichi, Utsuno, Atsushi, Yoshida, Satoshi, Ueyama, Eiji
Published in Diabetology international (01.06.2015)
Published in Diabetology international (01.06.2015)
Get full text
Journal Article
Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study (the SPOTLIGHT study)
Kashiwagi, Atsunori, Shiga, Takanori, Akiyama, Noriko, Kazuta, Kenichi, Utsuno, Atsushi, Yoshida, Satoshi, Ueyama, Eiji
Published in Diabetology international (01.06.2015)
Published in Diabetology international (01.06.2015)
Get full text
Journal Article
Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus
Saito, Masako, Kaibara, Atsunori, Kadokura, Takeshi, Toyoshima, Junko, Yoshida, Satoshi, Kazuta, Kenichi, Ueyama, Eiji
Published in Diabetes therapy (01.04.2020)
Published in Diabetes therapy (01.04.2020)
Get full text
Journal Article
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials
Kashiwagi, Atsunori, Yoshida, Satoshi, Nakamura, Ichiro, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Satomi, Hayato, Kosakai, Yoshinori, Kawamuki, Kosei
Published in Journal of diabetes investigation (01.07.2016)
Published in Journal of diabetes investigation (01.07.2016)
Get full text
Journal Article
Effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials
Kashiwagi, Atsunori, Yoshida, Satoshi, Kawamuki, Kosei, Nakamura, Ichiro, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Akiyama, Noriko, Kondo, Yoshinori, Ogihara, Toshio
Published in Diabetology international (01.03.2017)
Published in Diabetology international (01.03.2017)
Get full text
Journal Article
Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin : a pooled analysis of six randomized, placebo-controlled trials
Atsunori Kashiwagi, Taishi Sakatani, Ichiro Nakamura, Noriko Akiyama, Kenichi Kazuta, Eiji Ueyama, Hideyuki Takahashi, Yoshinori Kosakai
Published in ENDOCRINE JOURNAL (2018)
Get full text
Published in ENDOCRINE JOURNAL (2018)
Journal Article
Pharmacokinetic and pharmacodynamic modelling for renal function dependent urinary glucose excretion effect of ipragliflozin, a selective sodium–glucose cotransporter 2 inhibitor, both in healthy subjects and patients with type 2 diabetes mellitus
Saito, Masako, Kaibara, Atsunori, Kadokura, Takeshi, Toyoshima, Junko, Yoshida, Satoshi, Kazuta, Kenichi, Ueyama, Eiji
Published in British journal of clinical pharmacology (01.08.2019)
Published in British journal of clinical pharmacology (01.08.2019)
Get full text
Journal Article
Mechanistic study on degradation of azelnidipine solution under radical initiator-based oxidative conditions
Ueyama, Eiji, Takahashi, Fumie, Ohashi, Jyunji, Konse, Tomonori, Kishi, Naoyuki, Kano, Kenji
Published in Journal of pharmaceutical and biomedical analysis (05.03.2012)
Published in Journal of pharmaceutical and biomedical analysis (05.03.2012)
Get full text
Journal Article